Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-046244
Filing Date
2021-11-29
Accepted
2021-11-29 18:19:53
Documents
2
Period of Report
2021-11-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15670
2 EX-24 DOCUMENT attachment1.htm EX-24 2940
  Complete submission text file 0000899243-21-046244.txt   20102
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 600 VANCOUVER WA 98660
Business Address
TIMMINS ALAN P (Reporting) CIK: 0001234898 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 211457785